Sanjiv Sharma, MD

Sanjiv Sharma,

MD, FACC, FSCAI


  • Office Address:

    Central Cardiology Medical Clinic
    2901 Sillect Ave. Bakersfield, CA.
    800-432-7824
    800-HEART24
    661-323-8384

  • Hospitail Appointments:

    • Bakersfield Heart Hospital
    • San Joaquin Community Hospital
    • Mercy Hospital
    • Bakersfield Memorial Hospital


Current Status:
  • Cardiologist, Central Cardiology Medical Clinic, 2000-present

Certifications:
  • Board Certified in Internal Medicine, 1996
  • Board Certified in Cardiovascular Disease, 1999
  • Board Certified in Interventional Cardiology, 2000

Positions:
    • Director of Research & Education
    • Chairman, Health Education and CME Committee
    • Interventional Cardiologist
    • Bakersfield Heart Hospital
    • Bakersfield, CA 93306
    • Clinical Instructor in Medicine
    • David Geffen UCLA School of Medicine
    • UCLA
    • Los Angeles, CA

Education:
  • 1983-88
    • Medical School: Degree: MBBS
    • All India Institute of Medical Sciences
    • New Delhi-110 023, India
  • 1981-83
    • Undergraduate Premedical: Degree: Premedical
    • Multani Mal Modi College and Punjabi University
    • Patiala 147 002, India
  • 1970-81
    • School: Yadavindra Public School
    • Patiala-147 001, India

Postgraduate Education:
  • Fellowships:
    • July 1999 - June 2000
      • Interventional Cardiology Fellowship
      • Cedars Sinai Medical Center
      • 8700 Beverly Blvd
      • Los Angeles, CA 90048

    • July 1996 - June 1999
      • Cardiology Fellowship
      • Division of Cardiology
      • West Los Angeles VA Medical Center
      • UCLA School of Medicine
      • Los Angeles,CA 90073


  • Residency:
    • July 1994 - June 1996
      • Department of Medicine
      • Boston University School of Medicine Combined Residency Program (Boston University Medical Center, Boston City Hospital and Boston VA Medical Center)
      • Boston University School of Medicine
      • Boston, MA

    • Oct 1993 - Jun 1994
      • Department of Medicine
      • Massachusetts General Hospital
      • Harvard Medical School
      • Boston, MA

    • Jan 1992-May 1993 (Senior Residency)
      • Department of Medicine
      • All India Institute of Medical Sciences
      • All India Institute of Medical Sciences

    • Jan 1989 - Dec 1991 (Junior Residency)
      • Department of Medicine
      • All India Institute of Medical Sciences
      • New Delhi-110 023, India
      • Degree: M.D.,Medicine (Postgraduate degree in Medicine)


Medical License:
  • Medical Board of California : A 056149
  • Commonwealth of Massachusetts Board of Medicine: 82219
  • Federal DEA license.
  • Passed FLEX in Pennsylvania,1993.
  • Examinations:
    • Board Certified in Internal Medicine by the American Board of Internal Medicine (ABIM). Passed the American Board of Internal Medicine (ABIM) Certification Examination, 1996 with 10th decile scores.
    • Board Certified in Cardiovascular Disease, by the American Board of Internal Medicine (ABIM). Passed the American Board of Internal Medicine (ABIM) Certification Examination, 1999 with 10th decile scores.
    • Board Certified in Interventional Cardiology, by the American Board of Internal Medicine (ABIM). Passed the American Board of Internal Medicine (ABIM) Certification Examination, 2000 with 10th decile scores.
    • FMGEMS SCORES
      • Part I : 91
      • Part II : 93
    • FLEX SCORES
      • Part I : 91
      • Part II : 87

      Awards:
      • School:
        • Merit Prizes in Classes IV, V, VI, VII, VIII and IX for Excellence in Academics.
        • Honor Cards in Classes IV and VII for full attendance.
        • Nalagarh Gold Medal for best aggregrate in Mathametics and Science in the Indian Certificate of Secondary Education (matriculation) in school,1981.

      • Collage:
        • Merit Prize for first position in English in PreUniversity class,1981.
        • Merit Prize for first position in English, Physics and Chemistry in Premedical class, 1982.
        • First Position in University in Premedical Examination of Punjabi University, 1983. Awarded University Gold Medal by Punjabi University, Patiala, 1983.
        • Selected as National Talent Scholar under the National Talent Search Scheme (100 scholars selected by written test and interview throughout India) by the National Council of Educational Research and Training(NCERT), New Delhi, 1982.
        • Roll of Honor for Excellence in Academics by Multani Mal Modi College, Patiala, 1983.
        • First position in entrance examination to Christian Medical College, Ludhiana, 1982.
        • Second position in PMT Medical College Entrance examination in Punjab State, 1983.
        • Qualified for admission to the MBBS course of the All India Institute of Medical Sciences, New Delhi on the basis of a competitive written examination (35 students selected every year from about 40,000 students writing the examination).

      • Medical School:
        • First Prize in Pharmacology.
        • Second position in aggregate in Second Professional MBBS.
        • First Prize in Gynecology and Obstetrics. Second position in aggregate in Final Professional MBBS.


      Research Projects:
        • Project:
          • Revascularization comparing surgery versus percutaneous coronary intervention for unprotected left main artery stenosis randomized evaluation (REVASCULARIZE) Trial

        • Investigators:
          • Raj Makkar, MD and Sanjiv Sharma, MD
          • Cardiovascular Intervention Center
          • Cedars Sinai Medical Center, Los Angeles and
          • Bakersfield Heart Hospital, Bakersfield, CA


        • Project:
          • Long term outcome of drug eluting stents in different patient subsets: diabetes mellitus, acute myocardial infarction and saphenous vein graft percutaneous coronary intervention.

        • Investigators:
          • Raj Makkar, MD and Sanjiv Sharma, MD
          • Cardiovascular Intervention Center
          • Cedars Sinai Medical Center, Los Angeles and
          • Bakersfield Heart Hospital, Bakersfield, CA


        • Project:
          • Strategies to prevent slow flow during saphenous vein graft percutaneous coronary interventions: Intragraft administration of abciximab and verapamil combined with direct stenting versus traditional PCI strategies.

        • Investigators:
          • Sanjiv Sharma, MD and Raj Makkar, MD
          • Cardiac Catheterization Laboratories
          • Cardiovascular Intervention Center
          • Cedars Sinai Medical Center, Los Angeles and
          • Bakersfield Heart Hospital, Bakersfield, CA


        • Project:
          • Study of the anti-proliferative efficacy of Suramin in the prevention of experimental in-stent restenosis in a porcine model.

        • Investigators:
          • Sanjiv Sharma, MD, and Raj Makkar, MD
          • Cardiovascular Intervention Center
          • Cedars Sinai Medical Center
          • Los Angeles, CA
          • Grant Appplication for the Braco/Society of Coronary Angiography and Interventions Grant, 2000.


        • Project:
          • Hematopoeitic cell transplantation in experimental myocardial infarction in a pig model.

        • Investigators:
          • Sanjiv Sharma, MD and Raj Makkar, MD
          • Cardiovascular Intervention Center
          • Cedars Sinai Medical Center
          • Los Angeles, CA


        • Project:
          • Outcome data on small vessel stenting-a clinical follow-up study.

        • Investigators:
          • Sanjiv Sharma,MD, Neal Eigler, MD and Raj Makkar, MD
          • Cardiovascular Intervention Center
          • Cedars Sinai Medical Center
          • Los Angeles, CA


        • Project:
          • Prediction of hemodynamic significance of intermediate coronary lesions in coronary arteries of diabetic versus nondiabetic patients using doppler flow wire.

        • Investigators:
          • Sanjiv Sharma,MD and Vishva Dev, MD
          • West Los Angeles VA Medical Center
          • UCLA School of Medicine,Los Angeles, CA
          • 1996-1999


        • Project:
          • Noninvasive estimation of pulmonary artery wedge pressure by dual-M-mode echocardiography.

        • Investigators:
          • Sanjiv Sharma,MD and Savitri Shrivastava, MD, DM
          • Echocardiography Laboratory, Cardiothoracic Center
          • All India Institute of Medical Sciences, New Delhi, India
          • Thesis submitted to the All India Institute of Medical Sciences for award of the postgraduate degree of Medicine, 1991.
          • 1989-1991


        • Project:
          • Effect of corticosteroid treatment on various serological and bronchoalveolar lavage abnormalities in patients with sarcoidosis.

        • Investigators:
          • Sanjiv Sharma,MD and Surender K. Sharma, MD
          • Bronchoscopy Laboratory, All India Institute of Medical Sciences, New Delhi, India.
          • 1992


        • Project:
          • Relationship between glucocorticoid receptor content in bronchoalveolar lavage fluid in sarcoidosis and response to steroid treatment.

        • Investigators:
          • Sanjiv Sharma, MD and Surender K. Sharma, MD
          • Bronchoscopy Laboratory, All India Institute of Medical Sciences, New Delhi, India.
          • 1992



      Research Trials:
      • COSTAR-II Trial. CObalt chromium STent with Antiproliferative for Restenosis). Sponsor: ConorMed.
      • Revascularization comparing surgery versus percutaneous coronary intervention for unprotected left main coronary artery stenosis randomized evaluation (REVASCULARIZE) Trial.
      • ASSENT 4 PCI-Assessment of the safety and efficacy of a new treatment strategy for acute myocardial infarction. Sponsor: Genentech.
      • Drug eluting stent Cover Registry. Sponsor: Cordis / Johnson & Johnson.
      • TRITON-TIMI 38-A comparison of CS-747 and clopidogrel in acute coronary syndrome patients undergoing PCI; a phase III, multicenter, radomized, parallel-group, double-blind, double-dummy, active controlled trial. Sponsor: TIMI Trials group.
      • TITAN-TIMI 34-Time to Integrilin therapy in acute myocardial infarction. Sponsor: TIMI Trials group.
      • Multicenter, randomized double blind placebo controlled efficacy and safety study to evaluate the effects of Tolvaptan (OPC-41061) on the chronic outcomes of patients with congestive heart failure. Sponsor: Otsuka.
      • REVIVE (Ranomized, multicenter Evaluation of intravenous Levosimendan efficacy versus placebo in the short term treatment of decompensated congestive heart failure). Sponsor: Orion.
      • A double blind randomized placebo controlled parrallel group multicenter flexible dose study to evaluate the efficacy and safety of Viagra (sildenafil citrate) in males with erectile dysfunction and coronary artery disease. Sponsor: Pfizer.
      • ATBAT Study-Anticoagulant therapy with bivalirudin to assist in the performance of percutaneous intervention in patients with heparin induced thrombocytopenia. Sponsor: The Medicines Company.
      • A double blind randomized placebo controlled parrallel group multicenter flexible dose study to evaluate the efficacy and safety of Viagra (sildenafil citrate) in males with erectile dysfunction and congestive heart failure. Sponsor: Pfizer.
      • Vasopressin inhibition with Tolvaptan assessment of long term efficacy (VITAL study) Sponsor: Otsuka
      • Clinical utility of Amlodipine/Atorvastatin to improve concomitant cardiovascular risk factors of hypertension and dyslipidemia (GEMINI study). Sponsor: Pfizer
      • WATCH-Warfarin and antiplatelet therapy in chronic heart failure.
      • RITZ 2-Tezosentan in congestive heart failure.
      • An open-label, community-based clinical practice study of Niaspan in patients with hyperlipidemia.
      • REACH registry-Reduction of atherothrombosis for continued health.
      • ADVANCE MI-Adressing the value of primary angioplasty after combination therapy or eptifibatide monotherapy in acute myocardial infarction.
      • EVEREST-Multi-center, randomized, double-blind, placebo-controlled study to evaluate the long term efficacy and safety of oral Tolvaptan in subjects hospitalized with worsening congestive heart failure.
      • IRIS-A 6-week, randomized, open-label, comparative study to evaluate the efficacy and safety of rosuvastatin and atorvastatin in the treatment of hypercholesterolemia in South Asian subjects.
      • EARLY ACS-Early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome; a randomized, placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST-segment elevation acute coronary syndromes.
      • ALT-711-Effect of Alagebrium in combination with fixed-dose hydrochlorthiazide therapy on systolic blood pressure in hypertensive patients.
      • PRIMO-CABG II- A multicenter, randomized, double-blind, parallel-group, placebo-controlled infusion of Pexelizumab in patients undergoing CABG with cardiopulmonary bypass.
      • AHEAD- Achieve hypertension efficacy with AMEAL S dietary supplement.

      Publications:
      • Sharma S, Bhambi B. Successful treatment of hypotension associated with stunned myocardium with oral midodrine therapy. J Cardiovasc Pharmacol Ther. 2005;10: 77-9.
      • Sharma S, Makkar RR, Bhambi B, Nyitray W, Desai K, Ishimori T. Intragraft administration of abciximab and verapamil combined with direct stenting prevents slow-flow and no-reflow phenomena in saphenous vein graft percutaneous coronary interventions. Catheter Cardiovasc Interv 2005; 65 B:119.B 43 (abstract).
      • Sharma S, Bhambi B. Vertebral artery stenting utilizing distal embolic protection withy Filter Wire and a drug eluting Taxus stent. (submitted)
      • Sharma S, Makkar RR,Lardizabal J. Intracoronary administration of abciximab (ReoPro) during percutaneous coronary interventions (PCI)-should this be the routine and preferred approach? (submitted)
      • Sharma S, Lardizabal J, Nyitray W, Florence M, File C, Roland M. Mitral Regurgitation Is A Prevalent Phenomenon In Patients With "lone" Atrial Afibrillation And May Be A Risk Factor For Causing "lone" Atrial Fibrillation. (submitted).
      • Sharma S, Nyitray W, Bhambi B.Glycoprotein IIb/IIIa inhibition in percutaneous coronary interventions. JAMA. 2003; 290:1451.
      • Sharma S, Bhambi B, Nyitray W, Desai K, Davis D, Sharma G, Shukla P, File C, Ishimori T. Bivalirudin (Angiomax) use during intracoronary brachytherapy may predispose to acute closure. J Cardiovasc Pharmacol Ther 2003; 8:9-15.
      • Sharma S, Forrester J, Makkar RM. The SOS study comparing coronary artery bypass graft surgery (CABG) with stenting. Lancet 2003; 361:614-5.
      • Sharma S, Bhambi B, Nyitray W. Sirolimus-eluting coronary stents. N Engl J Med 2002; 347: 1285.
      • Sharma S, Nyitray W, Bhambi B. Brachytherapy and saphenous vein grafts. N Engl J Med 2002; 347: 692.
      • Sharma S, Bhambi B, Ishimori T. A better control for ICD patients? Eur Heart J 2002; 23:1972.
      • Sharma S, Bhambi B, Nyitray W, Desai K, Sharma G, Shukla P, Antonescu A, Denny E, Richardson K, Sadberry R, Ishimori T. Intragraft administration of abciximab and verapamil combined with direct stenting prevents slow-flow during saphenous vein graft percutaneous coronary interventions. Am J Cardiol 2002; 154 H.
      • Sharma S, Bhambi B, Nyitray W, Sharma G, Shambaugh S, Antonescu A, Shukla P, Denny E. Delayed profound thrombocytopenia presenting 7 days after use of abciximab (ReoPro). J Cardiovasc Pharmacol Ther 2002; 7(1):21-24.
      • Sharma S, Makkar RM. Percutaneous Intervention on the LIMA -tackling the tortuosity. J Invasive Cardiol. 2003;15:359-62.
      • Sharma S. Miscellaneous medical complications in pregnancy. Obstetrics Gynaecology Today, 1999; 4:259-261.
      • Sharma S. Thromboembolic disorders in pregnancy and puerperium. Obstetrics Gynaecology Today, 1999;4:324.
      • Sharma S, Eagle KA. Monitoring the pulmonary artery wedge pressure in medical patients: value, limitations and complications. Am Fam Physician 1996; 54:1039-49.
      • Sharma SK, Khanna M, Sharma S, Srivastava LM, Verma K, Khilnani GC, Pande JN. Effect of corticosteroid treatment on various serological and bronchoalveolar lavage abnormalities in patients with sarcoidosis. Indian J Med Res 1995;101: 207-12.
      • Sharma SK, Vij U, Sharma S, Murugasen K, Verma K, Pande JN. Glucocorticoid receptor content in bronchoalveolar lavage fluid in sarcoidosis and its relevance to steroid treatment. Am J Respir Crit Care Med 1994; 148: A 606 (abstract).
      • Sharma S, Goswami KC,Shrivastava S,Sharma SK. Noninvasive estimation of pulmonary artery wedge pressure by dual -M- mode echocardiography. J Assoc Physicians India 1994; 42:298-99.
      • Khilnani GC, Sharma SK, Sharma S, Srivastava LM, Verma K, Khanna M, Pande JN. Effect of corticosteroid treatment on various serological and bronchoalveolar lavage abnormalities in patients with sarcoidosis. Am Rev Respir Dis 1993; 147 :A 89 (abstract).
      • Sharma S, Wasir HS. Myocardial revascularization in acute myocardial infarction. J Assoc Physicians India 1993; 41:103-109.
      • Sharma SK, Sharma S, Mukhopadhyay S. Mediastinal paraganglioma presenting as an intracardiac mass with superior vena cava obstruction. Thorax 1993; 48:1181-82.
      • Sharma S, Goswami KC, Shrivastava S, Sharma SK. Noninvasive estimation of pulmonary artery wedge pressure by dual -M- mode echocardiography. Indian Heart J 1992; 44:281 (abstract).
      • Sharma SK, Sharma S, Mukhopadhyay S, Padhy AK, Vijayaraghavan M. Pulmonary alveolar microlithiasis. Indian J Chest Dis Allied Sci 1992;34: 205-15.
      • Sharma JB, Buckshee K, Sharma S. Puberty menorrhagia due to Bernard Soulier syndrome and its successful treatment by Ovral hormonal tablets. Aust N Z J Obstet Gynaecol 1991;31:369-70.
      • Ramesh V, Tanwar RK, Kaushal R, Vaid ,Rath GK, Gupta R, Sharma S, Choubey RP. Oesophageal carcinoma in association with Non-Hodgkin's lymphoma. J Inst Medicine 1991;13: 296-300.
      • Sharma JB, Tiwari S, Gulati N, Sharma Sanjiv. Schmidt's syndrome : a rare cause of puberty menorrhagia. International J Gynecology Obstetrics 1990;33: 373-75.

      Book Chapters:
      • Sharma Sanjiv. Medical Complications in Pregnancy. In Sharma JB. The Obstetric Protocol. New Delhi, Jaypee Brothers,1998, Pp 75-148.

      Editorial Boards:
      • Manuscript Reviewer, The Lancet,London,United Kingdom.
      • Manuscript Reviewer: The Journal of Cardiovascular Pharmacology and Therapeutics, Los Angeles, CA
      • Consulting Editor, Obstetrics Gynaecology Today, New Delhi, India.

      Consultancies:
      • Consultant to the Central Complaint Unit of the Medical Board of California, Sacramento,CA. 2005-now. Responsibilties include reviewing medical records in complaints and malpractice cases filed against physicians and providing expert opinion and recommendations to the Medical Board of California.
      • Invited by the American Board of Internal Medicine (ABIM) to review questions set for the American Board of Internal Medicine (ABIM) Interventional Cardiology Certification Examination, 2005.
      • Invited by the American Board of Internal Medicine (ABIM) to set questions for the. American Board of Internal Medicine (ABIM) Cardiovascular Disease Re-certification Examination, 2002.
      • Invited by the American Board of Internal Medicine (ABIM) to review questions set for the American Board of Internal Medicine (ABIM) Cardiovascular Disease Re-certification Examination, 2001.
      • Director of Research & Education, Bakersfield Heart Hospital, Bakersfield, CA 2003-now.
      • Member, Institutional Research Board (IRB) Committee, Bakersfield Heart Hospital, Bakersfield, CA 2001

      Original Inventions, Procedures and Patents:
      • New atraumatic guiding catheter for coronary angioplasty: Patent to be filed in the future. This invention allows cannulation of the coronary arteries without any trauma and is proposed to reduce the likelihood of guide induced trauma during angioplasty.
      • New percutaneous coronary intervention technique for treatment of saphenous vein bypass grafts utilizing intragraft administration of abciximab and verapamil combined with direct stenting to prevent slow-flow and no-reflow phenomenon.
      • New percutaneous coronary intervention technique for treatment of tortuous internal mammary artery bypass graft.

      Conference Presentations:
      • Intragraft administration of abciximab and verapamil combined with direct stenting prevents slow-flow and no-reflow phenomena in saphenous vein graft percutaneous coronary interventions. Society of Cardiac Angiography and Interventions. Ponte Vedra Beach, FL. May 2005.
      • Intragraft administration of abciximab and verapamil combined with direct stenting prevents slow-flow during saphenous vein graft percutaneous coronary interventions. Presented at the Transcatheter Cardiovascular Therapeutics, Washington DC 2002.
      • Intravascular Brachytherapy with Rhenium-188 balloon: Radiant Pilot Study. Presented at the American College of Cardiology Meeting, Anaheim, CA 2000.
      • Glucocorticoid receptor content in bronchoalveolar lavage fluid in sarcoidosis and its relevance to steroid treatment. Presented at the American Thoracic Society Meeting, Boston, MA 1994.
      • Effect of corticosteroid treatment on various serological and bronchoalveolar lavage abnormalities in patients with sarcoidosis. Presented at the American Thoracic Society Meeting , San Francisco, CA 1993.
      • Noninvasive estimation of pulmonary artery wedge pressure by dual -M- mode echocardiography. Presented at the 44 th Annual Conference of the Cardiological Society of India, New Delhi, India 1992.
      • Spectrum of myelodysplastic syndrome in India. Presented at the XXX Annual Conference of the Indian Society of Hematology and Blood Transfusion, Berhampur, India 1989.

      Invited Presentations and Lectures:
      • Approach to Coronary artery disease and Acute Coronary Syndromes. Kern Valley Hospital, Lake Isabella, CA. December 2002.
      • Drug-Eluting Coronary Stents: Update on data from SIRIUS-400 and TAXUS trials. Cardiac Catheterization Conference, Bakersfield Heart Hospital, Bakersfield, CA October 2002.
      • Management of Acute Coronary Syndromes. Dept. of Family Practice Conference, Kern Medical Center, Bakersfield, CA September, 2002.
      • Drug-Eluting Coronary Stents: Basic design, mechanisms and review of RAVEL study. Cardiac Catheterization Conference, Bakersfield Heart Hospital, Bakersfield, CA August 2002.
      • Approach to Acute Coronary Syndromes. Nurses Conference, Bakersfield Memorial Hospital, Bakersfield, CA September 2001.
      • Approach to chest pain syndromes. Nurse Practitioner Course Lecture series. California State University Bakersfield, Bakersfield, CA April 2001.
      • Post Angioplasty Care from a nursing perspective. Cardiac Care Nurses Conference. Bakersfield Heart Hospital, Bakersfield, CA March 2001.
      • Interventional Cardiology Update. Dept. of Medicine Conference. Kern Medical Center, Bakersfield, CA.October 2000.
      • Technical considerations in Internal Mammary Artery (IMA) Coronary Interventions. Cardiac Catheterization Conference. Cedars Sinai Medical Center, Los Angeles, CA June 2000.
      • Percutaneous Cardiopulmonary Bypass Support (PCPS) and PCPS-supported high risk angioplasty. Cardiac Catheterization Conference. Cedars Sinai Medical Center, Los Angeles, CA May 2000.
      • Cardiac Allograft Vasculopathy. Cardiac Catheterization Conference, Cedars Sinai Medical Center, Los Angeles. February 2000.
      • Management of Isolated Left Anterior Descending coronary artery disease- Angioplasty vs. Stent vs. bypass surgery. Interventional Cardiology Journal Club Rounds. Cedars Sinai Medical Center, Los Angeles, CA February 2000.
      • Pulmonary artery catheterization. Dept. of Medicine Conference. Kern Medical Center, Bakersfield, CA February 2000.
      • Cilostazol and restenosis after coronary stenting: review of studies. Interventional Cardiology Journal Club Rounds. Cedars Sinai Medical Center, Los Angeles, CA December 1999.
      • Percutaneous Coronary Interventions for Saphenous Vein Graft Disease. Cardiac Catheterization Conference. Cedars Sinai Medical Center, Los Angeles, CA November 1999.
      • Neointimal Hyperplasia and mechanisms of instent restenosis after coronary stenting procedures. Interventional Cardiology Journal Club Rounds. Cedars Sinai Medical Center, Los Angeles, CA November 1999.
      • Spontaneous Coronary Dissection. Cardiac Catheterization Conference, Cedars Sinai Medical Center, Los Angeles, CA October 1999.
      • Qunatitative Coronary Angiography (QCA) of Stent Restenosis in SCRIPPS Trial. Interventional Cardiology Journal Club Rounds. Cedars Sinai Medical Center, Los Angeles, CA September 1999.
      • Angioplasty and stenting of the left main coronary artery. Cardiac Catheterization Conference. Cedars Sinai Medical Center, Los Angeles, CA August 1999.
      • Primary Stenting Versus Balloon Angioplasty in Occluded Coronary Arteries: The Total Occlusion Study of Canada. Interventional Cardiology Journal Club Rounds. Cedars Sinai Medical Center, Los Angeles, CA August 1999.
      • Effectiveness of Clopidogrel and Aspirin versus Ticlopidine and Aspirin in stent implantation. Interventional Cardiology Journal Club Rounds. Cedars Sinai Medical Center, Los Angeles, CA July 1999.
      • Pharmacology of the Thienopyridine derivatives, Ticlopidine and Clopidogrel, in relation to coronary stenting procedures. Interventional Cardiology Journal Club Rounds. Cedars Sinai Medical Center, Los Angeles, CA July 1999.
      • Randomized clinical trials of Coronary Artery Bypass Graft versus Percutaneous Transluminal Coronary Angioplasty. Cardiology Grand Rounds. West Los Angeles VA Medical Center,Los Angeles, CA June 1999.
      • Stenting of Unprotected Left Main Coronary Artery Stenoses: Immediate and Late Outcomes. Cardiology Journal Club Rounds. Oliveview-UCLA Medical Center, Los Angeles, CA February 1998.
      • A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias: AVID Trial. Cardiology Journal Club Rounds. West Los Angeles VA Medical Center, Los Angeles, CA December 1997.
      • Prediction of hemodynamic significance of intermediate coronary lesions in coronary arteries of diabetic versus nondiabetic patients using doppler flow wire. Research Conference. West Los Angeles VA Medical Center, Los Angeles, CA November 1997.
      • Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization: EPILOG Study. Cardiology Journal Club Rounds. West Los Angeles VA Medical Center, Los Angeles, CA June 1997.
      • Management of Hypertension. Graduating Senior Resident Talk. Boston University School of Medicine Residency Program, Boston, MA June 1996.
      • Myocardial revascularization in acute myocardial infarction. Dept of Medicine Journal Club Rounds. All India Institute of Medical Sciences, New Delhi, India. 1990.
      • Mediastinal paraganglioma presenting as an intracardiac mass with superior vena cava obstruction. Medical Grand Rounds, All India Institute of Medical Sciences (AIIMS), New Delhi, India, 1990.
      • Pulmonary alveolar microlithiasis. Medical Grand Rounds. All India Institute of Medical Sciences, New Delhi, India. 1989.
      • New Treatment strategies in the management of Bronchial Asthma. Dept of Medicine Journal Club Rounds, All India Institute of Medical Sciences, New Delhi, India. 1989.

      Memberships of Societies:
      • Fellow, Society of Cardiac Angiography and Interventions, 2003.
      • Fellow of the American College of Cardiology (FACC), 2002.
      • Member, American Heart Association Council on Cardiovascular Radiology and Intervention, 2002.
      • Member, American Heart Association Council on Clinical Cardiology, 2000.
      • Member, American Medical Association, 2000.
      • Member, California Medical Association, 2000.
      • Member, Kern County Medical Society, 2000.
      • Affiliate Member, Society of Cardiac Angiography and Interventions, 2000.
      • Associate Fellow-in-Training, American College of Cardiology, 1996
      • Member, American Academy for Advancement of Science (by invitation), 1994.
      • Member, The Massachusetts Medical Society,1994.